Toxins in blood plasma

"Toxins in blood plasma" refers collectively to various exogenous (e.g., bacterial toxins like Shiga toxin[1], mycotoxins[2][6][7], brevetoxins[3]) and endogenous toxic compounds that may be detected in the plasma component of blood. These molecules do not represent a defined single biological entity or pharmacological target; rather, they span multiple chemical families (such as proteins, peptides, small organic molecules, and metabolites). They may originate from bacterial infection, mold contamination of food, marine toxins, or as metabolites of drugs and environmental chemicals. The physiological consequences of these toxins depend on their molecular identity and mechanism of action, such as ribosome inactivation (Shiga toxin[1]), ion channel modulation (brevetoxins[3]), or enzyme inhibition (various mycotoxins[2][7]). Monitoring toxins in plasma is an important aspect of toxicology, clinical chemistry, and occupational/environmental health but does not correspond to a specific molecular target suitable for drug development or therapeutic intervention.\n\nKey points for later structuring:\n- This is not a therapeutic target such as a receptor, enzyme, transporter, or gene product.\n- The phrase is too broad, non-specific, and refers to a class, not a canonical molecule.\n- To obtain structured target information, a specific toxin (e.g., \"Shiga toxin\", \"Aflatoxin B1\", etc.) must be specified[1][2][3][7].